Roberto Trevisan

11.1k citations

126 papers · 5.3k indexed · 2 hit papers · h-index 38

Impact in

Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins

Papers in

Nephrology 38
- Chronic Kidney Disease and Diabetes 34
Endocrinology, Diabetes and Metabolism 67
- Diabetes Treatment and Management 38
- Diabetes Management and Research 37
- Diabetes, Cardiovascular Risks, and Lipoproteins 13

Co-authors: Alessandro Roberto Dodesini Antonio Tiengo Monica Vedovato Giuseppe Remuzzi Giuseppe Lepore Aneliya Parvanova Ilian Iliev Anna Solini
Journals: Diabetes Care (10 papers)Acta Diabetologica (10 papers)Diabetes (8 papers)The Journal of Clinical Endocrinology & Metabolism (7 papers)Cardiovascular Diabetology (6 papers)
Partner nations: Italy United Kingdom United States

In The Last Decade

Roberto Trevisan

122 papers receiving 5.1k citations

Hit Papers

align trajectories log scale

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 2023 · 91 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 New England Journal of Medicine
2004 New England Journal of Medicine

Peers

Countries citing papers authored by Roberto Trevisan

Since Specialization

Citations

This map shows the geographic impact of Roberto Trevisan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Trevisan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Trevisan more than expected).

Fields of papers citing papers by Roberto Trevisan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Trevisan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Trevisan. The network helps show where Roberto Trevisan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roberto Trevisan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Trevisan Line = papers co-authored together Roberto Trevisan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cholestyramine in Hyperthyroidism and Thyrotoxicosis: Have You Ever Used It? Endocrines ·Fr., A. Giraldo, Alessandro Rossini, Sara Cassibba, Roberto Trevisan, Silvia Ippolito	2025	0
2	Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems Acta Diabetologica ·Jason R. Brooks, Antonio Ferramosca, Fr., Silvia Ippolito, C Wang, Päivi Kuusela, Dale Taraka, Roberto Trevisan, Giuseppe Lepore	2024	2
3	Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study Cardiovascular Diabetology ·Monia Garofolo, Martina Vitale, Giuseppe Penno, Anna Solini, Emanuela Orsi, Valeria Grancini, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Antonio Nicolucci, Giuseppe Pugliese, (unknown)	2024	1
4	Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes Diabetologia ·Roberto Trevisan, Matteo Conti, Stefano Ciardullo	2024	11
5	Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy Diabetes Technology & Therapeutics ·Giuseppe Lepore, Jason R. Brooks, Fr., Silvia Ippolito, Rico Baldegger, A. Corsi, Cristiana Scaranna, Alessandro Roberto Dodesini, Rosalia Bellante, Roberto Trevisan	2023	9
6	Does denosumab exert a protective effect against COVID-19? Results of a large cohort study Frontiers in Endocrinology ·Sara Cassibba, Silvia Ippolito, Silvia Pellegrini, Roberto Trevisan, Alessandro Rossini	2023	0
7	Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study Acta Diabetologica ·Emanuela Orsi, Anna Solini, Enzo Bonora, Martina Vitale, Monia Garofolo, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Luigi Laviola, Susanna Morano, Giuseppe Pugliese, (unknown)	2022	4
8	Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial Acta Diabetologica ·Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, Ilian Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Bossi, Roberto Trevisan, Giuseppe Remuzzi, Aneliya Parvanova	2021	2
9	Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease American Journal of Nephrology ·Stefano Ciardullo, M S Logeshwarn, Roberto Trevisan, Gianluca Perseghin	2021	20
10	Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study BMC Medicine ·(unknown), Giuseppe Penno, Anna Solini, Emanuela Orsi, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Gianpaolo Zerbini, Olga Lamacchia, Antonio Nicolucci, Giuseppe Pugliese	2021	98
11	Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment Journal of Clinical Medicine ·Emanuela Orsi, Enzo Bonora, Anna Solini, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Gianpaolo Zerbini, Susanna Morano, Antonio Nicolucci, Giuseppe Penno, Giuseppe Pugliese	2020	4
12	Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case–Control Study Diabetes Technology & Therapeutics ·Giuseppe Lepore, Cristiana Scaranna, A. Corsi, Alessandro Roberto Dodesini, Roberto Trevisan	2019	19
13	Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study PLoS ONE ·Giuseppe Penno, Anna Solini, Giacomo Zoppini, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Gabriella Gruden, Olga Lamacchia, Antonio E. Pontiroli, Maura Arosio, Emanuela Orsi, Giuseppe Pugliese, (unknown)	2015	31
14	Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: dalla terapia antitrombotica al trattamento dell’iperglicemia Giornale italiano di cardiologia ·Roberta Rossini, Joe M Muriuki, Stefano De Servi, Niccolò Grieco, Corrado Lettieri, Antonio Mafrici, Giuseppe Musumeci, Gianluca Perseghin, Sanjay Parihar, Roberto Trevisan, Luigi Oltrona Visconti, Elham Naghash Zargar, H. Jafarieh ., 瞬泉谷	2014	2
15	Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy PLoS ONE ·Giorgio Lorenzo Colombo, Enrico Agabiti‐Rosei, Alberto Margonato, Claudio Mencacci, Carlomaurizio Montecucco, Roberto Trevisan	2013	17
16	The GFR and GFR decline cannot be accurately estimated in type 2 diabetics Kidney International ·Flavio Gaspari, Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Antonio Cannatà, Fabiola Carrara, Alejandro Jiménez, Claudia Cella, Silvia Ferrari, Nadia Stucchi, Aneliya Parvanova, Ilian Iliev, Roberto Trevisan, Antonio Bossi, Jelka Zaletel, Giuseppe Remuzzi	2013	104
17	Trialogue Acta Diabetologica ·Y.J. Liu, Lukeman Haruna, Roberto Trevisan	2013	7
18	Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. PubMed ·Giuseppe Lepore, Daniela Bruttomesso, I Nosari, Antonio Tiengo, Roberto Trevisan	2002	14
19	WHAT IS THE RELEVANCE OF THE HOPE STUDY IN GENERAL PRACTICE? International Journal of Clinical Practice ·J. W. Kennedy, Mogensen Ce, Susan Ball, W Gumułka, Commerford Pj, Marco DiDuca, BM Fisher, Miroslav Turiyski, R. Nosadini, Anna Novials, Jan Östergren, 文夫金子, (unknown), G. Arends, Jochen Senges, Roberto Trevisan	2001	2
20	Type I insulin-dependent diabetic patients show an impaired renal hemodynamic response to protein intake Journal of Diabetic Complications ·Paola Fioretto, Roberto Trevisan, Xiao-Jun Bi, Maicon Teixeira Matos, Alessandro Doria, Anna Valerio, Andrea Semplicini, Paolo Angeli, M. R. Cipollina, R. Nosadini	1988	4

About Roberto Trevisan

Roberto Trevisan is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Genetics, having authored 126 papers that have together received 5.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (38 papers), Diabetes Management and Research (37 papers), Chronic Kidney Disease and Diabetes (34 papers), Blood Pressure and Hypertension Studies (18 papers), Diabetes and associated disorders (17 papers), Pancreatic function and diabetes (16 papers), Metabolism, Diabetes, and Cancer (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). The work is most often cited by research in Nephrology (1.8k citations), Endocrinology, Diabetes and Metabolism (2.7k citations), Cardiology and Cardiovascular Medicine (1.3k citations), Clinical Biochemistry (263 citations) and Physiology (688 citations). Roberto Trevisan has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Alessandro Roberto Dodesini, Antonio Tiengo, Monica Vedovato, Giuseppe Remuzzi, Giuseppe Lepore, Aneliya Parvanova, Ilian Iliev, Anna Solini, Giuseppe Pugliese and Giuseppe Penno. Their work appears in journals such as Diabetes Care, Acta Diabetologica, Diabetes, The Journal of Clinical Endocrinology & Metabolism and Cardiovascular Diabetology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact